Patient-controlled Analgesia Pumps Market Outlook for (2023 to 2033)

The global Patient-controlled Analgesia Pumps Market is anticipated to register a CAGR of 5% during the forecast period. The global market valuation is US$ 447 million in 2023 and is expected to reach US$ 729.1 million by 2033.

The increasing prevalence of chronic diseases such as cardiovascular disease is increasing the demand for patient-controlled analgesia pumps. The growing number of cancer cases and performed surgeries are fueling the global market size. Healthcare professionals are increasing the demand for patient-controlled analgesia pumps to manage patients' post-operative pain.

The growing aging population, expanding healthcare infrastructure, and increasing chronic pain are significantly driving the global market. Rapidly growing advanced technologies are developing safe, efficient, and user-friendly devices to improve patient outcomes. Enhanced drug delivery systems integrated with electronic health records help to monitor patients' health.

The adoption of portable patient-controlled analgesia pumps for home healthcare is driving the global market trend. Patients prefer these devices with cost-effective solutions to reduce hospital costs. Healthcare manufacturers are promoting patients' health by developing standardized devices with stringent regulatory guidelines.

Increasing awareness through education campaign and training programs are ensuring patients about the benefits of patient-controlled analgesia devices. The key companies are partnering with pharmaceutical companies to increase the adoption of smart technologies to promote their advanced products.

Key Highlights

  • In 2021, in the United States, around 92.1 million people were affected with cardiovascular disease as compared to other chronic diseases.
  • Increasing cases of cancer in Germany is boosting the sales of patient-controlled analgesia.
  • The rising generic population and number of chronic patients are advancing China market.
Attributes Details
Patient-controlled Analgesia Pumps Market Size, 2023 US$ 447 million
Patient-controlled Analgesia Pumps Market Size, 2033 US$ 729.1 million
Value-based CAGR from 2023 to 2033 5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance and Future Growth Prospects in Patient-controlled Analgesia Pumps Market

The global Patient-controlled Analgesia Pumps Market grew at a significant rate between 2018 and 2022. The global market captured a valuation of US$ 421.9 million with a CAGR of 5.1% in 2022. Healthcare professionals are increasing the adoption of patient-controlled analgesia devices to deliver the required drugs at the right place.

Around 50% of patients are hospitalized due to chronic pain, and 30% suffer persistent pain due to cancer disease. Patients who are facing moderate or little pain are increasing the adoption of portable patient-controlled analgesia devices at home. The rapidly growing advanced technologies in the healthcare sector are improving patient outcomes.

Key companies are integrating smart devices to relieve chronic patients and satisfy their needs. The adoption of sophisticated, wireless, and user-friendly equipment is expanding the patient-controlled analgesia pumps market size. These companies are likely to achieve their goals by acquiring maximum revenue during the forecast period.

Country-wise Insights

Countries Share (2023 to 2033)
United States 32.6%
Japan 4.3%
Germany 7.1%
Countries CAGR (2023 to 2033)
Australia 5.6%
China 5.1%
India 5.3%
United Kingdom 4.5%

Chronic Patients Upsurge in the United States Market

The United States is estimated to capture a share of 32.6% of the global market by 2033. The growing numbers of generic patients, diabetes patients, and advanced healthcare settings are fueling the United States patient-controlled analgesia pumps market. The United States is likely to dominate the global market due to the higher rate of chronic disorders in the country.

In 2019, the most common deadly disease in the United States was kidney disease. Around 80 million people suffer from kidney disease in the country. Healthcare professionals are adopting patient-controlled analgesia devices during patients' surgical processes to minimize pain.

Increasing Cancer Cases Drive Germany Market

Germany contributes a significant share of 7.1% in the global market during the forecast period. The increasing number of cancer cases, rising disposable income, and diabetes patients are expanding Germany's patient-controlled analgesia pumps market.

Key companies are developing advanced technical healthcare devices to enhance patient outcomes. They are offering flexible, cost-effective, portable, and improved devices to satisfy end users' demand; according to a report by the WHO, around 628,519 new cases of cancer disease found in Germany in 2020. These incidences are uplifting the demand for patient-controlled analgesia pumps in the country.

Advanced Healthcare Infrastructure Fuel China Market

China is one of the significant countries that secured a CAGR of 5.1% in the global market during the forecast period. The increasing old age population, advanced healthcare technologies, and essential key players are expanding the China patient-controlled Analgesia pumps market.

In 2019, according to the WHO report, 176 million people suffered from chronic diseases. The increasing generic population is raising the demand for patient-controlled analgesia pumps. The growing pharmaceuticals, healthcare services, and medical devices are contributing significant role in the country.

The integration of artificial intelligence and the Internet of Things in healthcare devices by essential key manufacturers is surging the China market. These manufacturers are regulating stringent regulations to offer high-quality products.

Growing Innovation and Aging Population Drive Japan Market

Japan is estimated to capture a share of 4.3% in the global market during the forecast period. Emerging economies, a high standard of living, and growing technologies are fueling the Japan market. On the other hand, the increasing population of the aging demographic is surging the demand for patient-controlled analgesia pumps.

Patients prefer high-quality, better service, and cost-effective solutions to improve their health conditions. Japan is a hub of innovation and technology. Healthcare providers adopting cutting-edge technologies such as robotics, automation, and electronics are driving the Japan market.

Japanese companies are adopting several strategies to build trustworthy relationships with their clients. The distribution channels play a crucial role in expanding global reach and finding relevant end users. They understand the needs of products and services across various end-use industries and are advancing Japan's market share.

Skilled Healthcare Professionals Stimulate Demand for Analgesia Pumps in India

India is estimated to secure a CAGR of 5.3% in the global market by 2033. The rising medical tourism enhanced medical treatment, and high-quality services are fueling India's patient-controlled analgesia pumps market. The government initiated several programs to offer healthcare services at lower costs. The highly skilled workforce is largely enhancing patients' healthcare with essential healthcare devices.

The rising pharmaceutical sector, innovations in drug therapies, and smart machine technologies are playing crucial roles in hospitals. Manufacturers are offering smart devices at affordable prices are fulfill end users' requirements. The rising urbanization, industrialization, and preferring patients' choice of treatment are advancing the Indian market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

PCA Pumps are Highly Sought-after in the Global Market

Category PCA Pumps
Share 75.5%

Based on product type, PCA pumps are estimated to capture a share of 75.5% during the forecast period. The demand for PCA pumps is widely increasing among hospitals to manage patients' pain after medical conditions and surgeries. These patient-managed pain relief pumps offer effective and flexible methods to relieve pain.

PCA pumps reduce the workload of service staff by providing self-administered medication. These pain relief pumps play a crucial role in patient care. PCA pumps are managing cancer pain with feature-rich devices and advanced medical devices. These factors are estimated to dominate the PCA pumps in the global market by 2033. On the other hand, pump accessories are also significantly fueling the global market by registering a better share of the market.

Chemo Therapy/ Oncology Upsurge the Global Market

Category Chemo therapy/ oncology
Share 36.6%

Based on application, the chemotherapy/oncology segment is likely to dominate the global market by capturing a share of 36.6% by 2033. The growing incidence of cancer is increasing the demand for chemotherapy/ oncology services to treat patients. The aging population suffers more prevalence of chronic disease, increasing the adoption of chemotherapy/ oncology services.

The growing technological advancements in diagnostic and cancer research institutions are improving chemotherapy to treat patients. The innovation of new drug therapies and other oncology therapies is advancing the global market revenue.

The growing awareness of early detection of cancer, awareness programs, and standardized treatment are increasing the demand for chemotherapy/ oncology. Pharmaceutical sectors are investing hugely in research and development activities.

The Hospital Sector dominates the Global Market

Category Hospital
Share 56.9%

Based on end-users, the hospital segment is likely to dominate the global market by registering a share of 56.9% by 2033. Rising diverse patients are increasing the demand for better healthcare services and products. Hospitals provide various healthcare specialists to treat patients' diseases, from medicine to surgical procedures.

The broad variety of services, advanced medical equipment, and suppliers are surging the global market size. Hospitals offer outpatient and inpatient services with the adoption of medical devices.

Hospitals offer excellent teaching facilities to enhance patient outcomes with their expertise. The government initiative plans a broader hospital sector to manage emergency medical care. It provides rehabilitation services for its patients.

Competitive Landscape in the Patient-controlled Analgesia Pumps Market

Key players are playing a crucial role in highlighting global market revenue upward. They analyze and research on market and come out with unique and advanced ideas to develop improved products. These key players are adopting various marketing methodologies such as mergers, collaborations, acquisitions, product launches, and partnerships.

Key market players are improving patients' health with their highly equipped healthcare devices. They are supporting their customers with their standardized products. These key players make their efforts to provide suitable devices and take feedback from their relevant consumers. They are changing their products according to end users' preferences with easy-to-use machines.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Players in the Patient-controlled Analgesia Pumps Market

  • Smiths Group plc.
  • Fresenius Kabi Group,
  • Hospira (Pfizer Inc.),
  • Micrel Medical Devices,
  • Ace Medical Co. Ltd.
  • Terumo Corporation,
  • B.Braun Melsungen AG
  • Baxter International
  • Becton Dickinson and Company.
  • BD
  • ICU Medical

Recent Developments in the Patient-controlled Analgesia Pumps Market

  • In 2022, Smiths Medical announced its partnership with Bainbridge Health. This partnership took place to enhance the portfolio in medication safety.
  • In 2022, BD announced its agreement with Parata Systems with an amount of US$ 1.525 billion.
  • In 2022, the United States FDA announced its approval of Baxten’s infusion pump Novum IQ syringe. This device improves post-surgery pain management.
  • In 2022, Shanghai MicroPort Lifesciences Co. Ltd announced its approval of AutoEx Chemotherapy Infusion pumps.

Key Segments in the Patient-controlled Analgesia Pumps Market

By Product:

  • PCA Pumps
  • Pump Accessories

By Application:

  • Chemo Therapy/Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home care settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Patient-controlled Analgesia Pumps Market?

The patient-controlled analgesia pumps market valuation is US$ 729.1 million in 2023.

Which is the Biggest Market for Patient-controlled Analgesia Pumps?

The United States is the biggest market for patient-controlled analgesia pumps.

What is the Patient-controlled Analgesia Pumps Market CAGR in 2023?

The patient-controlled analgesia pumps market is likely to capture a CAGR of 5% in 2023.

What is the Current Market Trend?

The growing focus on portable patient-controlled analgesia devices.

Who are the Key Players in the Patient-controlled Analgesia Pumps Market?

ICU Medical, Ace Medical Co. Ltd., and Baxter International are the key players in the patient-controlled analgesia market.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
        5.3.1. PCA Pumps
        5.3.2. Pump Accessories
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
        6.3.1. Chemo Therapy/Oncology
        6.3.2. Pediatrics/Neonatology
        6.3.3. Gastroenterology
        6.3.4. Hematology
    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Home care settings
    7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Western Europe
        8.3.4. Eastern Europe
        8.3.5. South Asia and Pacific
        8.3.6. East Asia
        8.3.7. Middle East and Africa
    8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. USA
            9.2.1.2. Canada
        9.2.2. By Product
        9.2.3. By Application
        9.2.4. By End-User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product
        9.3.3. By Application
        9.3.4. By End-User
    9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Product
        10.2.3. By Application
        10.2.4. By End-User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By Application
        10.3.4. By End-User
    10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. UK
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Western Europe
        11.2.2. By Product
        11.2.3. By Application
        11.2.4. By End-User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Application
        11.3.4. By End-User
    11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Poland
            12.2.1.2. Russia
            12.2.1.3. Czech Republic
            12.2.1.4. Romania
            12.2.1.5. Rest of Eastern Europe
        12.2.2. By Product
        12.2.3. By Application
        12.2.4. By End-User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Application
        12.3.4. By End-User
    12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. India
            13.2.1.2. Bangladesh
            13.2.1.3. Australia
            13.2.1.4. New Zealand
            13.2.1.5. Rest of South Asia and Pacific
        13.2.2. By Product
        13.2.3. By Application
        13.2.4. By End-User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Application
        13.3.4. By End-User
    13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. South Korea
        14.2.2. By Product
        14.2.3. By Application
        14.2.4. By End-User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Application
        14.3.4. By End-User
    14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. GCC Countries
            15.2.1.2. South Africa
            15.2.1.3. Israel
            15.2.1.4. Rest of MEA
        15.2.2. By Product
        15.2.3. By Application
        15.2.4. By End-User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Application
        15.3.4. By End-User
    15.4. Key Takeaways
16. Key Countries Market Analysis
    16.1. USA
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Product
            16.1.2.2. By Application
            16.1.2.3. By End-User
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Product
            16.2.2.2. By Application
            16.2.2.3. By End-User
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Product
            16.3.2.2. By Application
            16.3.2.3. By End-User
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Product
            16.4.2.2. By Application
            16.4.2.3. By End-User
    16.5. Germany
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Product
            16.5.2.2. By Application
            16.5.2.3. By End-User
    16.6. UK
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Product
            16.6.2.2. By Application
            16.6.2.3. By End-User
    16.7. France
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Product
            16.7.2.2. By Application
            16.7.2.3. By End-User
    16.8. Spain
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Product
            16.8.2.2. By Application
            16.8.2.3. By End-User
    16.9. Italy
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Product
            16.9.2.2. By Application
            16.9.2.3. By End-User
    16.10. Poland
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Product
            16.10.2.2. By Application
            16.10.2.3. By End-User
    16.11. Russia
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Product
            16.11.2.2. By Application
            16.11.2.3. By End-User
    16.12. Czech Republic
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Product
            16.12.2.2. By Application
            16.12.2.3. By End-User
    16.13. Romania
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Product
            16.13.2.2. By Application
            16.13.2.3. By End-User
    16.14. India
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Product
            16.14.2.2. By Application
            16.14.2.3. By End-User
    16.15. Bangladesh
        16.15.1. Pricing Analysis
        16.15.2. Market Share Analysis, 2022
            16.15.2.1. By Product
            16.15.2.2. By Application
            16.15.2.3. By End-User
    16.16. Australia
        16.16.1. Pricing Analysis
        16.16.2. Market Share Analysis, 2022
            16.16.2.1. By Product
            16.16.2.2. By Application
            16.16.2.3. By End-User
    16.17. New Zealand
        16.17.1. Pricing Analysis
        16.17.2. Market Share Analysis, 2022
            16.17.2.1. By Product
            16.17.2.2. By Application
            16.17.2.3. By End-User
    16.18. China
        16.18.1. Pricing Analysis
        16.18.2. Market Share Analysis, 2022
            16.18.2.1. By Product
            16.18.2.2. By Application
            16.18.2.3. By End-User
    16.19. Japan
        16.19.1. Pricing Analysis
        16.19.2. Market Share Analysis, 2022
            16.19.2.1. By Product
            16.19.2.2. By Application
            16.19.2.3. By End-User
    16.20. South Korea
        16.20.1. Pricing Analysis
        16.20.2. Market Share Analysis, 2022
            16.20.2.1. By Product
            16.20.2.2. By Application
            16.20.2.3. By End-User
    16.21. GCC Countries
        16.21.1. Pricing Analysis
        16.21.2. Market Share Analysis, 2022
            16.21.2.1. By Product
            16.21.2.2. By Application
            16.21.2.3. By End-User
    16.22. South Africa
        16.22.1. Pricing Analysis
        16.22.2. Market Share Analysis, 2022
            16.22.2.1. By Product
            16.22.2.2. By Application
            16.22.2.3. By End-User
    16.23. Israel
        16.23.1. Pricing Analysis
        16.23.2. Market Share Analysis, 2022
            16.23.2.1. By Product
            16.23.2.2. By Application
            16.23.2.3. By End-User
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Product
        17.3.3. By Application
        17.3.4. By End-User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Smiths Group plc.
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
                18.1.1.5.2. Product Strategy
                18.1.1.5.3. Channel Strategy
        18.1.2. Fresenius Kabi Group,
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
                18.1.2.5.2. Product Strategy
                18.1.2.5.3. Channel Strategy
        18.1.3. Hospira (Pfizer Inc.),
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
                18.1.3.5.2. Product Strategy
                18.1.3.5.3. Channel Strategy
        18.1.4. Micrel Medical Devices,
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
                18.1.4.5.2. Product Strategy
                18.1.4.5.3. Channel Strategy
        18.1.5. Ace Medical Co. Ltd.
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
                18.1.5.5.2. Product Strategy
                18.1.5.5.3. Channel Strategy
        18.1.6. Terumo Corporation,
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
                18.1.6.5.2. Product Strategy
                18.1.6.5.3. Channel Strategy
        18.1.7. B.Braun Melsungen AG
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
                18.1.7.5.2. Product Strategy
                18.1.7.5.3. Channel Strategy
        18.1.8. Baxter International
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
                18.1.8.5.2. Product Strategy
                18.1.8.5.3. Channel Strategy
        18.1.9. Becton Dickinson and Company.
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
                18.1.9.5.2. Product Strategy
                18.1.9.5.3. Channel Strategy
        18.1.10. BD
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
                18.1.10.5.2. Product Strategy
                18.1.10.5.3. Channel Strategy
        18.1.11. ICU Medical
            18.1.11.1. Overview
            18.1.11.2. Product Portfolio
            18.1.11.3. Profitability by Market Segments
            18.1.11.4. Sales Footprint
            18.1.11.5. Strategy Overview
                18.1.11.5.1. Marketing Strategy
                18.1.11.5.2. Product Strategy
                18.1.11.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Recommendations

Healthcare

Patient Portal Market

July 2024

REP-GB-2069

345 pages

Healthcare

Patient Handling Equipment Market

June 2024

REP-GB-1201

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Patient-Controlled Analgesia Pumps Market

Schedule a Call